Ortho Clinical Diagnostics - a Johnson & Johnson Company.
Global Sites
:
New Zealand (English)
Argentina (Español)
Australia (English)
Belgium (English)
Bolivia (Español)
Brazil (Português)
Canada (English)
Chile (Español)
Colombia (Español)
Costa Rica (Español)
Dominican Republic (Español)
Ecuador (Español)
El Salvador (Español)
France (Français)
Germany (Deutsch)
Guatemala (Español)
Honduras (Español)
Hong Kong SAR (English)
India (English)
Italy (Italiano)
Jamaica (English)
Japan (Japanese)
Mexico (Español)
Netherlands (Nederlands)
New Zealand (English)
Nicaragua (Español)
Panama (Español)
Peru (Español)
Puerto Rico (English)
Scandinavia (English)
Spain (Español)
Trinidad & Tobago (English)
United Kingdom (English)
United States (English)
Uruguay (Español)
Venezuela (Español)
Search:
Search
Our Commitment
Product Information
Customer Toolkit
Technical Documents
Training & Education
Services & Support
Ortho Connect
Clinical Laboratories
Transfusion Medicine
Request Product Information
Control Assay Sheets
Instructions For Use Library
MSDS
Clinical Laboratory Tech Docs
Immunohematology Tech Docs
Donor Screening Tech Documents
VITROS® VITAL Topics
Event Calendar
Product Training
ValuMetrix Consulting Services
Product Training
Customer Service
Technical Support
Register for Updates ›
Media |
Press Releases
Contact Information
|
Johnson & Johnson, Our Parent
|
Press Kit
|
Press Releases
Introducing the new VITROS® Immunodiagnostic Products Syphilis TPA Assay
ORTHO CLINICAL DIAGNOSTICS LAUNCHES “BLOODLINES” BRAND CAMPAIGN INSPIRED BY BLOOD BANKERS
Ortho Clinical Diagnostics Launches 24-Hour Remote Monitoring Center (July 21, 2009)
FDA Approves VITROS® Anti-HCV Assay For Use On VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnostic Systems (July 21, 2009)
Veridex Announces Agreement To Acquire The Assets of Immunicon Corporation (June 11, 2008)
Johnson & Johnson Nordic AB Acquires AMIC (June 18, 2008)